Hartford Financial Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.45K | Hold |
10
| – | – | ﹤0.01% | 296 |
|
|
2025
Q1 | $4.85K | Hold |
10
| – | – | ﹤0.01% | 305 |
|
|
2024
Q4 | $4.03K | Hold |
10
| – | – | ﹤0.01% | 324 |
|
|
2024
Q3 | $4.65K | Hold |
10
| – | – | ﹤0.01% | 326 |
|
|
2024
Q2 | $4.69K | Hold |
10
| – | – | ﹤0.01% | 328 |
|
|
2024
Q1 | $4.18K | Hold |
10
| – | – | ﹤0.01% | 336 |
|
|
2023
Q4 | $4.07K | Sell |
10
-9
| -47% | -$3.66K | ﹤0.01% | 340 |
|
|
2023
Q3 | $6.61K | Hold |
19
| – | – | ﹤0.01% | 323 |
|
|
2023
Q2 | $6.69K | Hold |
19
| – | – | ﹤0.01% | 304 |
|
|
2023
Q1 | $5.99K | Hold |
19
| – | – | ﹤0.01% | 304 |
|
|
2022
Q4 | $5.49K | Hold |
19
| – | – | ﹤0.01% | 306 |
|
|
2022
Q3 | $6K | Sell |
19
-5
| -21% | -$1.58K | ﹤0.01% | 306 |
|
|
2022
Q2 | $7K | Hold |
24
| – | – | ﹤0.01% | 301 |
|
|
2022
Q1 | $6K | Buy |
+24
| New | +$6K | ﹤0.01% | 326 |
|
|
2018
Q3 | – | Sell |
-670
| Closed | -$114K | – | 424 |
|
|
2018
Q2 | $114K | Hold |
670
| – | – | 0.04% | 186 |
|
|
2018
Q1 | $109K | Hold |
670
| – | – | 0.06% | 152 |
|
|
2017
Q4 | $100K | Hold |
670
| – | – | 0.05% | 158 |
|
|
2017
Q3 | $101K | Hold |
670
| – | – | 0.05% | 158 |
|
|
2017
Q2 | $86K | Hold |
670
| – | – | 0.04% | 170 |
|
|
2017
Q1 | $73K | Buy |
+670
| New | +$73K | 0.04% | 165 |
|